Applied Medical Resources Corp. v. United States Surgical Corp.

967 F. Supp. 861, 43 U.S.P.Q. 2d (BNA) 1688, 1997 U.S. Dist. LEXIS 8410, 1997 WL 321700
CourtDistrict Court, E.D. Virginia
DecidedJune 10, 1997
DocketCivil Action 96-1217-A
StatusPublished
Cited by10 cases

This text of 967 F. Supp. 861 (Applied Medical Resources Corp. v. United States Surgical Corp.) is published on Counsel Stack Legal Research, covering District Court, E.D. Virginia primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Applied Medical Resources Corp. v. United States Surgical Corp., 967 F. Supp. 861, 43 U.S.P.Q. 2d (BNA) 1688, 1997 U.S. Dist. LEXIS 8410, 1997 WL 321700 (E.D. Va. 1997).

Opinion

MEMORANDUM OPINION

ELLIS, District Judge.

This patent infringement action came before the Court for trial by jury on April 15, 1997. In the course of a jury trial that spanned fourteen days, the parties presented testimonial and documentary evidence on the issues raised by the complaint of plaintiff Applied Medical Resources Corporation (“Applied”) and the answer and counterclaim of defendant United States Surgical Corporation (“Surgical”), namely,

(1) whether surgical trocar products manufactured and sold by Surgical infringed certain claims of three United States Patents owned by Applied covering surgical trocar seal technology;

(2) whether Surgical’s infringement, if any, was willful;

(3) whether Applied’s patent claims alleged to be infringed were invalid;

(4) the amount of damages, if any, suffered by Applied as a result of Surgical’s infringement;

(5) whether surgical trocar products manufactured and sold by Applied infringed a *863 claim of a United States Patent owned by Surgical covering surgical trocar safety latch and shield technology;

(6) whether Applied’s infringement, if any, was willful;

(7) whether Surgical’s patent claim alleged to be infringed was invalid; and

(8) the amount of damages, if any, suffered by Surgical as a result of Applied’s infringement.

At the conclusion of the evidence, arguments of counsel, and the Court’s instructions, the matter was submitted to the jury, which after one and one-half days of deliberation returned a unanimous verdict in favor of Applied. Specifically, the jury found that Surgical willfully infringed each of the asserted claims of Applied’s patents in suit, and that none of these asserted claims was invalid. Having made these findings, the jury then assessed compensatory damages in the form of a seven percent (7%) royalty on Surgical’s sale of infringing products. Finally, the jury concluded that Applied had not infringed the asserted claim of Surgical’s patent in suit.

The matter is now before the Court on Applied’s motion requesting (i) enhanced damages, and (ii) attorneys’ fees. The matter has been argued orally and in writing, and is now ripe for disposition.

I.

The Patent Act permits a court to increase damages awarded in infringement actions “up to three times the amount found or assessed.” 35 U.S.C. § 284. The decision whether to increase damages, and the determination of the amount of any increase, is within the discretion of the trial court and is informed by the totality of the circumstances of the matter litigated. See, e.g., American Medical Sys. Inc. v. Medical Engineering Corp., 6 F.3d 1523, 1532 (Fed.Cir.1993), cert. denied, 511 U.S. 1070, 114 S.Ct. 1647, 128 L.Ed.2d 366 (1994). The damages enhancement decision involves a two-step process. First, willful infringement must be established at trial. See, e.g., Delta-X Corp. v. Baker Hughes Prod. Tools, Inc., 984 F.2d 410, 413 (Fed.Cir.1993). Next, the district court must decide whether to exercise its discretion to enhance damages up to three times the amount awarded to the prevailing party. Id. Applied has proven willful infringement at trial. Thus, the Court must now determine the amount of enhanced damages, if any, to award to Applied in this matter.

A finding of willful infringement does not require an increase in damages, much less the trebling of damages. See, e.g., Goodwall Const. Co. v. Beers Const. Co., 991 F.2d 751, 758 (Fed.Cir.1993). To the contrary, even where willful infringement is established, enhanced damages may be avoided where an infringer mounts a meritorious good-faith defense and a strong challenge to infringement. See, e.g., Delta-X Corp., 984 F.2d at 413. Yet, where a jury has found willful infringement, a district court must provide reasons for refusing to enhance damages. See Jurgens v. CBK. Ltd., 80 F.3d 1566, 1572 (Fed.Cir.1996). And in so doing, the district court must take care to avoid second guessing the jury or contradicting its findings. Id. at 1572-74. 1

In awarding enhanced damages, a district court considers both aggravating and mitigating circumstances in an effort to gauge or assess, in a qualitative fashion, the egregiousness of the infringer’s conduct. See, e.g., Read Corp. v. Portec, Inc., 970 F.2d 816, 826 (Fed.Cir.1992). This is so because “[t]he amount of enhancement must bear some relationship to the level of culpability of the conduct.” Graco, Inc. v. Binks Mfg. Co., 60 F.3d 785, 794 n. 4 (Fed.Cir.1995). The *864 Federal Circuit has articulated nine factors that district courts should consider in assessing an infringer’s culpability and the appropriate amount of enhanced damages. See Read, 970 F.2d at 827. Specifically, these nine factors are:

1. whether the infringer deliberately copied the ideas or design of another;

2. whether the infringer investigated the scope of the patent and formed a good-faith belief that it was invalid or that it was not infringed;

3. the infringer’s behavior as a party to the litigation;

4. the infringer’s size and financial condition;

5. the closeness of the case;

6. the duration of the infringer’s misconduct;

7. remedial action by the infringer;

8. the infringer’s motivation for the harm; and

9. the infringer’s attempts to conceal its infringement.

Id. at 827.

As the nature of these factors suggests, a district court’s assessment of the propriety and amount of enhanced damages is necessarily qualitative, not quantitative. The essential goal, at least in part, is to evaluate “the degree of the infringer’s culpability....” Read, 970 F.2d at 828. For this there is no mathematical formula, nor any quantitative prescription that yields a precise result. Rather, district courts must exercise their best judgment after careful consideration of all relevant circumstances, including the nine Read factors. And as further confirmation of the qualitative nature of the assessment required, the district court’s decision in this regard is reviewed on an abuse of discretion standard.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Applied Medical Resources Corp. v. United States Surgical Corp.
549 F. Supp. 2d 1208 (C.D. California, 2008)
Informatica Corp. v. Business Objects Data Integration, Inc.
489 F. Supp. 2d 1075 (N.D. California, 2007)
Tristrata Technology, Inc. v. ICN Pharmaceuticals, Inc.
314 F. Supp. 2d 356 (D. Delaware, 2004)
nCUBE Corp. v. SeaChange International, Inc.
313 F. Supp. 2d 361 (D. Delaware, 2004)
Aspex Eyewear, Inc. v. E'Lite Optik, Inc.
276 F. Supp. 2d 1084 (D. Nevada, 2003)
Odetics, Inc. v. Storage Technology Corp.
14 F. Supp. 2d 800 (E.D. Virginia, 1998)

Cite This Page — Counsel Stack

Bluebook (online)
967 F. Supp. 861, 43 U.S.P.Q. 2d (BNA) 1688, 1997 U.S. Dist. LEXIS 8410, 1997 WL 321700, Counsel Stack Legal Research, https://law.counselstack.com/opinion/applied-medical-resources-corp-v-united-states-surgical-corp-vaed-1997.